BioLife Solutions
BLFS
195 hedge funds and large institutions have $1.13B invested in BioLife Solutions in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 65 reducing their positions, and 4 closing their positions.
775% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 4
72% more call options, than puts
Call options by funds: $210K | Put options by funds: $122K
19% more funds holding
Funds holding: 164 → 195 (+31)
13% more capital invested
Capital invested by funds: $1B → $1.13B (+$133M)
3.34% less ownership
Funds ownership: 101.42% → 98.09% (-3.3%)
11% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 65
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$8.97M |
| 2 |
Rockefeller Capital Management
New York
|
+$6.2M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$4.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$13.6M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$9.97M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$9.72M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.78M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.24M |
BLFS Hedge Fund Activity: Q3 2024 in Review
195 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2024, worth a combined $1.13B — up 13% from $1B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new BLFS positions and 4 closed out — a net gain of 31 holders — while 58 added to existing stakes and 65 trimmed.
The largest buyer was VOYA Investment Management, adding an estimated $8.97M. The largest seller was Portolan Capital Management, cutting an estimated $13.6M.
- 195 institutional investors held BioLife Solutions (BLFS) as of Q3 2024, up from 164 in Q2 2024.
- Funds reported $1.13B of BioLife Solutions stock for Q3 2024, up 13% quarter-over-quarter.
- 35 funds opened new BioLife Solutions positions in Q3 2024 and 4 closed out, a net change of +31 holders.
- The largest BioLife Solutions buyer in Q3 2024 was VOYA Investment Management, an estimated $8.97M added.
- The largest BioLife Solutions seller in Q3 2024 was Portolan Capital Management, an estimated $13.6M sold.
Based on aggregated 13F filings for Q3 2024.